(Q57758618)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9541691%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

title

Oxaliplatin as single agent in previously untreated colorectal carcinoma patients: a phase II multicentric study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9541691%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

0 references

1 reference

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9541691%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Roberto Labianca

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9541691%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

Filippo de Braud

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9541691%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

author name string

J Sastre

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9541691%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

A Zaniboni

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9541691%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

H Cortés-Funes

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9541691%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

C Boni

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9541691%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Benavides

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9541691%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

G Dallavalle

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9541691%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

M Homerin

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9541691%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

publication date

1 January 1998

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9541691%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9541691%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

volume

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9541691%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9541691%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

page(s)

105-108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9541691%20AND%20SRC:MED&resulttype=core&format=json

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

10 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200825886

7 January 2021

The benefit of leucovorin-modulated fluorouracil as postoperative adjuvant therapy for primary colon cancer: results from National Surgical Adjuvant Breast and Bowel Project protocol C-03

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200825886

7 January 2021

Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200825886

7 January 2021

Modulation of fluorouracil by leucovorin in patients with advanced colorectal cancer: evidence in terms of response rate. Advanced Colorectal Cancer Meta-Analysis Project

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200825886

7 January 2021

Randomized study of continuous infusion fluorouracil versus fluorouracil plus cisplatin in patients with metastatic colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200825886

7 January 2021

Antitumor activity of a new platinum complex, oxalato (trans-l-1,2-diaminocyclohexane)platinum (II): new experimental data

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200825886

7 January 2021

Phase I study of oxaliplatin in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200825886

7 January 2021

Two consecutive phase II studies of oxaliplatin (L-OHP) for treatment of patients with advanced colorectal carcinoma who were resistant to previous treatment with fluoropyrimidines

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200825886

7 January 2021

Oxaliplatin activity against metastatic colorectal cancer. A phase II study of 5-day continuous venous infusion at circadian rhythm modulated rate

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200825886

7 January 2021

CPT-11 (Irinotecan) in the treatment of colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200825886

7 January 2021

Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200825886

7 January 2021

Final results of a randomised trial comparing 'Tomudex' (raltitrexed) with 5-fluorouracil plus leucovorin in advanced colorectal cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008200825886

7 January 2021

Identifiers

DOI

10.1023/A:1008200825886

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9541691%20AND%20SRC:MED&resulttype=core&format=json

10 November 2019

1 reference